Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Assets (2023 - 2025)

Historic Return on Assets for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q3 2025 value amounting to 0.09%.

  • Indivior Pharmaceuticals' Return on Assets rose 500.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.0% for FY2024, which is 800.0% up from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Return on Assets of 0.09% as of Q3 2025, which was up 500.0% from 0.08% recorded in Q2 2025.
  • In the past 5 years, Indivior Pharmaceuticals' Return on Assets ranged from a high of 0.09% in Q3 2025 and a low of 0.22% during Q3 2023
  • For the 3-year period, Indivior Pharmaceuticals' Return on Assets averaged around 0.03%, with its median value being 0.01% (2025).
  • Data for Indivior Pharmaceuticals' Return on Assets shows a peak YoY increase of 2600bps (in 2024) and a maximum YoY decrease of -700bps (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Indivior Pharmaceuticals' Return on Assets stood at 0.0% in 2023, then surged by 554bps to 0.01% in 2024, then skyrocketed by 1686bps to 0.09% in 2025.
  • Its Return on Assets was 0.09% in Q3 2025, compared to 0.08% in Q2 2025 and 0.01% in Q1 2025.